CAPR•benzinga•
Capricor Accepted By FDA For Deramiocel BLA Filing For DMD Cardiomyopathy, Priority Review Granted, PDUFA Date Set For August 31, 2025; NS Pharma To Commercialize In U.S.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 10, 2025 by benzinga